|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | |
| A61K 47/10 | |||
| A61K 47/26 | |||
| A61P 3/10 |
| (11) | Number of the document | 2494983 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12153063.8 |
| Date of filing the European patent application | 2005-11-14 | |
| (97) | Date of publication of the European application | 2012-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 200401753 | 2004-11-12 | DK | |
| 200401906 | 2004-12-08 | DK | |
| 05104050 | 2005-05-13 | EP | |
| 05104172 | 2005-05-18 | EP | |
| PCT/EP2005/0559 | 2005-11-11 | WO |
| (72) |
Ludvigsen, Svend, DK
Schlein, Morten, DK
B ving, Tine Elisabeth Gottschalk, DK
Bonde, Claude, DK
Lille re, Anne-Mette, DK
Engelund, Dorthe Kot, DK
Nielsen, Bjarne R nfeldt, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | STABLE FORMULATIONS OF GLP-1 |
| STABLE FORMULATIONS OF GLP-1 |